ReviewBiometals : an international journal on the role of metal ions in biology, biochemistry, and medicine2026
Metal oxide nanoparticles: emerging stars in biomedical application.
Review in Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bacterial metabolite-directed synthesis of biogenic TiORSC advances · 2026Article
- Metallo-herb complexes as emerging therapeutics: chemistry, synthesis approaches, and pharmacological insights.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The unique properties of nanoparticles have sparked intense research interest, driving innovation in production methodologies. Biological synthesis of nanoparticles has emerged as a game-changer, offering an efficient, cost-effective, and eco-friendly alternative. A diverse array of organisms, including bacteria, fungi, yeast, algae, and plants, can biosynthesize metallic nanoparticles with varying sizes and shapes through reduction reactions. A comprehensive analysis of existing literature reveals the bio reduction capabilities of bacterial biomass and extracts under different experimental conditions, providing valuable insights into this promising field. The applications of biosynthesized nanoparticles are vast, with notable potential in antimicrobial and anticancer activities. By exploring the achievements and current status of bacterial-mediated biosynthesis, this study aims to shed light on the opportunities and challenges in this rapidly evolving field. The surge in nanoparticle research is largely driven by the unexpected variations in surface properties that occur when particle size is reduced to the nanoscale, resulting in enhanced features such as particle size distribution and shape. The reduction of particle size to the nanoscale displays unique and improved features, including particle size distribution and shape. This variation in specific surface area is responsible for its high value, which influences critical factors such as surface reactivity. Gold particles have been employed for medicinal and Ayurvedic purposes in India and China since ancient times. Metal nanoparticles are being used globally in biomedicine and related fields. Researchers are currently focused on metal nanoparticles, nanostructures, and nanomaterial production due to their unique features. This paper examines various metal oxide nanoparticle preparation processes, including their benefits, drawbacks, and potential applications.
Indexed as
Identifiers
41307821What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.